CAR-T Referral Process: Insights from UCSF : Episode 9
CAR T-Cell Therapy in Multiple Myeloma: Lessons Learned and Key Takeaways
Panelists discuss how UCSF Health has learned that successful integration of CAR T-cell therapy in multiple myeloma requires multidisciplinary collaboration, patient selection optimization, and management of toxicities. Future research includes exploring CAR T-cell therapy in earlier treatment lines and combining it with novel agents to enhance efficacy.
Video content above is prompted by the following:
- What are the most important lessons your institution has learned in the integration of CAR T-cell therapy into the multiple myeloma treatment landscape?
- Looking ahead, what are your institution’s plans or considerations for further expanding the role of CAR T-cell therapy in earlier lines of multiple myeloma treatment?
Recent Videos
Related Content
